Leslie V. Norwalk
7 stock trades in the last 12 months, shares they bought or sold themselves (not grants or options).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
The 3 newest of 7 trades
| Stock | Trade | Amount | Traded |
|---|---|---|---|
| Sell(10b5-1 plan) | $228K | Jul 28SEC filing | |
| Sell(10b5-1 plan) | $210K | Jun 4SEC filing | |
| Sell(10b5-1 plan) | $591K | May 12SEC filing |
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Leslie V. Norwalk's companies
| Stock | Trades | Quality Score |
|---|---|---|
| 5 | ||
| 0 | ||
| 0 | ||
| 2 |
Alerts for Leslie V. Norwalk
Use this page
How to cite
Breakaway, Leslie V. Norwalk: Director at Neurocrine Biosciences (NBIX), Jul 30, 2026, getbreakaway.com/insiders/leslie-v-norwalk
Journalists: email support@getbreakaway.com for the data behind this page.